Page 193 - The Memory Program How to Prevent Memory Loss and Enhance Memory Power
P. 193

Page 182

            change the substance it produces at will. Occasionally, a hyperactive immune system can mistakenly
            attack the body's own tissues, as happens in rheumatoid arthritis and lupus. On the flip side, a weak
            immune system that does not destroy wayward cancerous cells can lead to malignant tumor
            formation, as occurs in AIDS.


            Inflammation in the Alzheimer's Brain

            Within the brain, the immune system interacts closely with nerve cells in several regions and is
            triggered in a variety of ways. The complement pathway (a sequence of enzymes/proteins) plays an
            important role in the immune response, and an overactive complement response can damage
            different areas of the brain. In patients with Alzheimer's disease, complement activation can trigger
            the formation of amyloid protein that collects in clumps to make up the pathologic amyloid plaques.
            Researchers are now studying anti-inflammatory agents that can block or inactivate complement in
            the treatment of not only Alzheimer's disease, but also mild to moderate memory loss during the
            aging process.

            Types of Anti-inflammatory Agents


            Anti-inflammatory medications are of two types: steroidal and nonsteroidal. It may seem odd that
            steroids, which in high concentrations can damage the hippocampus, can be therapeutic for patients
            with dementia. However, the fact that inflammation does occur in the brains of these patients
            suggests that steroids, which have extremely powerful anti-inflammatory properties, may indeed be
            effective treatments. Drs. Paul Aisen and Ken Davis at the Mount Sinai Medical Center in New York
            certainly think so, and they recently completed a placebo-controlled clinical trial using prednisone, a
            synthetic steroid, in Alzheimer's disease. However, the trial results were negative: prednisone
            showed no advantage over placebo in these patients.


              The other approach is to use nonsteroidal anti-inflammatory medications (NSAIDs) like
            acetylsalicylic acid (aspirin), indomethacin (Indocin), or ibuprofen (Motrin). Acetaminophen
            (Tylenol) has weak anti-inflammatory properties compared to aspirin, even though it has similar
            pain-killing strength.
   188   189   190   191   192   193   194   195   196   197   198